For some people battling major depression, a new medical treatment that sends magnetic pulses into the brain has been found to be effective. Studies also show that treatment can be effective in reducing migraine headaches and helping stroke victims regain mobility and motor skills. Treatment with Transcranial Magnetic Stimulation (TMS) uses magnetic pulses to stimulate the nerve cells in the brain. It is a non-invasive ambulatory procedure, indicating that in a hospital, it does not require medication, chemotherapy or healing period. Previous findings found that people using TMS treatment had a 50 per cent decrease in symptoms of depression. Visit FLORIDA TMS CLINIC.
Federal Drug Administration ( FDA) approves TMS therapy for use on adult patients who have tried antidepressant medication but have not seen any results. TMS treatment is currently available throughout the country from a few selected providers, and is not yet routinely covered by health insurance plans. How TMS therapy works is administered by lightly placing a treatment coil against a patient’s scalp while they are sitting in a reclining chair. The coil then directly emits magnetic fields to the portion of the brain involved in mood regulation. The magnetic fields produce the small electric currents. The currents alter cell activity in the brain which is believed to be effective in reducing symptoms of depression.
TMS therapy takes roughly 40 minutes a day, with patients fully awake in the process. Usually, patients are offered five weekly treatments over a six week span. Scalp pain or irritation-usually mild to moderate-was the most frequent side effect correlated with therapy during clinical trials. Studies have found that most TMS patients respond best to 40 consecutive magnetic pulses being treated twice a minute to the brain over a four second period. However, length, size, and amount of stimuli obtained each session depend on how the patient reacts to the medication being administered by the doctor. Lower rates of relapse in depression Two recent studies suggest that people with major depression were less likely to recur following diagnosis with TMS due to medicine or electroconvulsive therapy ( ECT). The studies found just 10 to 12 per cent of patients whose disorder initially went into remission following diagnosis with TMS.
The TMS findings in a strong comparison to the relapse incidence of 40 percent encountered by people experiencing recovery in an anti-depression drug trial, a figure close to those reported by ECT people. At the conference of the American Psychiatric Association this year, the two separately published TMS experiments were presented.